(firstQuint)Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders.

 The objective for the study is to establish chimerism following reduced intensity conditioning with no grade III/IV GVHD.

 The primary endpoint we will follow is production of the missing enzyme at 10% of the normal level at day 180 post-transplant in > 90% of patients.

.

 Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders@highlight

The goal of this research study is to establish chimerism and avoid graft-versus-host-disease (GVHD) in patients with inherited metabolic disorders.

